Corrigendum | Open Access
Luju Lai, Xiaoyun Shen, Haoqin Liang, Yingying Deng, Zhuandi Gong, Suocheng Wei, "Corrigendum to “Determine the Role of FSH Receptor Binding Inhibitor in Regulating Ovarian Follicles Development and Expression of FSHR and ERα in Mice”", BioMed Research International, vol. 2020, Article ID 5464070, 1 page, 2020. https://doi.org/10.1155/2020/5464070
Corrigendum to “Determine the Role of FSH Receptor Binding Inhibitor in Regulating Ovarian Follicles Development and Expression of FSHR and ERα in Mice”
In the article titled “Determine the Role of FSH Receptor Binding Inhibitor in Regulating Ovarian Follicles Development and Expression of FSHR and ERα in Mice” , Figure 1 and Table 1 presented results duplicated from the authors’ previous article . This was raised to our attention by a reader, and the authors explained that the experiments were designed and performed in two stages.
In the animal experiments of the first stage, three doses (20, 30, and 40 mg/kg) of FSH receptor binding inhibitor (FRBI) were intramuscularly injected into mice, respectively. The authors found FRBI could dose-dependently reduce the ovarian cortex thickness (OCT) and ovarian weights of mice. In the second stage, the authors designed four doses of FRBI in order to verify these outcomes.
The results in Figure 1 and Table 1 represented the results of these experiments, and the main results in each article overlapped except the FRBI-4 group. The duplicated results are accurately reported. The authors apologize that some results were repeated without this being explained, and the editorial board agreed with the publication of this corrigendum.
- L. Lai, X. Shen, H. Liang, Y. Deng, Z. Gong, and S. Wei, “Determine the role of FSH receptor binding inhibitor in regulating ovarian follicles development and expression of FSHR and ERα in mice,” BioMed Research International, vol. 2018, Article ID 5032875, 8 pages, 2018.
- G. Zhuandi, C. Tuanjie, L. Luju et al., “FSH receptor binding inhibitor restrains follicular development and possibly attenuates carcinogenesis of ovarian cancer through down-regulating expression levels of FSHR and ERβ in normal ovarian tissues,” Gene, vol. 668, pp. 174–181, 2018.
Copyright © 2020 Luju Lai et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.